| Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters CP Lai, EY Kim, CE Badr, R Weissleder, TR Mempel, BA Tannous, ... Nature communications 6 (1), 7029, 2015 | 569 | 2015 |
| A secreted luciferase for ex vivo monitoring of in vivo processes T Wurdinger, C Badr, L Pike, R De Kleine, R Weissleder, XO Breakefield, ... Nature methods 5 (2), 171-173, 2008 | 361 | 2008 |
| Bioluminescence imaging: progress and applications CE Badr, BA Tannous Trends in biotechnology 29 (12), 624-633, 2011 | 334 | 2011 |
| A highly sensitive assay for monitoring the secretory pathway and ER stress CE Badr, JW Hewett, XO Breakefield, BA Tannous PloS one 2 (6), e571, 2007 | 157 | 2007 |
| Triple bioluminescence imaging for in vivo monitoring of cellular processes CA Maguire, MS Bovenberg, MHW Crommentuijn, JM Niers, M Kerami, ... Molecular Therapy-Nucleic Acids 2, 2013 | 111 | 2013 |
| Real-time monitoring of nuclear factor κB activity in cultured cells and in animal models CE Badr, JM Niers, LA Tjon-Kon-Fat, DP Noske, T Wurdinger, ... Molecular imaging 8 (5), 7290.2009. 00026, 2009 | 98 | 2009 |
| Stearoyl CoA desaturase is essential for regulation of endoplasmic reticulum homeostasis and tumor growth in glioblastoma cancer stem cells K Pinkham, DJ Park, A Hashemiaghdam, AB Kirov, I Adam, K Rosiak, ... Stem cell reports 12 (4), 712-727, 2019 | 75 | 2019 |
| Bioluminescence imaging: basics and practical limitations CE Badr Bioluminescent Imaging: Methods and Protocols, 1-18, 2014 | 73 | 2014 |
| Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor–related apoptosis-inducing ligand and induces an alternative cell death pathway CE Badr, T Wurdinger, J Nilsson, JM Niers, M Whalen, A Degterev, ... Neuro-oncology 13 (11), 1213-1224, 2011 | 66 | 2011 |
| Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models J Teng, C Carla da Hora, RS Kantar, I Nakano, H Wakimoto, TT Batchelor, ... Neuro-oncology 19 (6), 820-832, 2017 | 58 | 2017 |
| Metabolic heterogeneity and adaptability in brain tumors CE Badr, DJ Silver, FA Siebzehnrubl, LP Deleyrolle Cellular and Molecular Life Sciences 77, 5101-5119, 2020 | 47 | 2020 |
| Functional drug screening assay reveals potential glioma therapeutics CE Badr, T Wurdinger, BA Tannous Assay and drug development technologies 9 (3), 281-289, 2011 | 40 | 2011 |
| Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery A Volak, SG LeRoy, JS Natasan, DJ Park, PS Cheah, A Maus, ... Journal of neuro-oncology 139, 293-305, 2018 | 29 | 2018 |
| Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model MHW Crommentuijn, R Kantar, DP Noske, WP Vandertop, CE Badr, ... Molecular Therapy-Oncolytics 3, 2016 | 27 | 2016 |
| Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy J Teng, S Hejazi, CE Badr, BA Tannous Stem cells 32 (8), 2021-2032, 2014 | 27 | 2014 |
| Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition CC da Hora, K Pinkham, L Carvalho, M Zinter, E Tabet, I Nakano, ... Cell death discovery 5 (1), 72, 2019 | 23 | 2019 |
| Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models KM Eyme, A Sammarco, R Jha, H Mnatsakanyan, C Pechdimaljian, ... Science translational medicine 15 (679), eabq6288, 2023 | 22 | 2023 |
| Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma MHW Crommentuijn, CA Maguire, JM Niers, WP Vandertop, CE Badr, ... Molecular oncology 10 (4), 625-634, 2016 | 22 | 2016 |
| Targeting cancer cells with the natural compound obtusaquinone CE Badr, S Van Hoppe, H Dumbuya, LA Tjon-Kon-Fat, BA Tannous Journal of the National Cancer Institute 105 (9), 643-653, 2013 | 22 | 2013 |
| Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A S Kazemi, S Kawaguchi, CE Badr, DR Mattos, A Ruiz-Saenz, JD Serrill, ... Biochemical pharmacology 183, 114317, 2021 | 21 | 2021 |
Tannous BAMassachusetts General Hospital and Harvard Medical School在 hms.harvard.edu 的电子邮件经过验证
